Ibio Common Stock Stock Price Patterns
| IBIO Stock | USD 2.42 0.27 12.56% |
Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.05) | EPS Estimate Current Year (0.26) | EPS Estimate Next Year (0.32) | Wall Street Target Price 4.72 | EPS Estimate Current Quarter (0.07) |
Using IBio Common hype-based prediction, you can estimate the value of iBio Common Stock from the perspective of IBio Common response to recently generated media hype and the effects of current headlines on its competitors.
iBio Common Stock Hype to Price Pattern
Investor biases related to IBio Common's public news can be used to forecast risks associated with an investment in IBio. The trend in average sentiment can be used to explain how an investor holding IBio can time the market purely based on public headlines and social activities around iBio Common Stock. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of IBio Common's market sentiment to its price can help taders to make decisions based on the overall investors consensus about IBio Common.
The fear of missing out, i.e., FOMO, can cause potential investors in IBio Common to buy its stock at a price that has no basis in reality. In that case, they are not buying IBio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
IBio Common after-hype prediction price | USD 2.78 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out IBio Common Basic Forecasting Models to cross-verify your projections. IBio Common After-Hype Price Density Analysis
As far as predicting the price of IBio Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in IBio Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of IBio Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
IBio Common Estimiated After-Hype Price Volatility
In the context of predicting IBio Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on IBio Common's historical news coverage. IBio Common's after-hype downside and upside margins for the prediction period are 0.14 and 13.16, respectively. We have considered IBio Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
IBio Common is dangerous at this time. Analysis and calculation of next after-hype price of iBio Common Stock is based on 3 months time horizon.
IBio Common Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as IBio Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IBio Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with IBio Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.51 | 10.38 | 0.36 | 0.06 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.42 | 2.78 | 14.88 |
|
IBio Common Hype Timeline
iBio Common Stock is currently traded for 2.42. The entity has historical hype elasticity of 0.36, and average elasticity to hype of competition of -0.06. IBio is forecasted to increase in value after the next headline, with the price projected to jump to 2.78 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 14.88%, whereas the daily expected return is currently at 1.51%. The volatility of related hype on IBio Common is about 24139.53%, with the expected price after the next announcement by competition of 2.36. iBio Common Stock currently holds 3.51 M in liabilities with Debt to Equity (D/E) ratio of 0.44, which is about average as compared to similar companies. iBio Common Stock has a current ratio of 1.45, which is within standard range for the sector. Note, when we think about IBio Common's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out IBio Common Basic Forecasting Models to cross-verify your projections.IBio Common Related Hype Analysis
Having access to credible news sources related to IBio Common's direct competition is more important than ever and may enhance your ability to predict IBio Common's future price movements. Getting to know how IBio Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how IBio Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ITRM | Iterum Therapeutics PLC | (0.02) | 7 per month | 0.00 | (0.16) | 9.38 | (8.89) | 28.58 | |
| PLUR | Pluri Inc | 0.17 | 8 per month | 4.38 | (0.01) | 9.90 | (6.07) | 31.25 | |
| INTS | Intensity Therapeutics Common | 0.02 | 6 per month | 0.00 | (0.1) | 10.87 | (11.63) | 51.11 | |
| RLYB | Rallybio Corp | (0.18) | 6 per month | 0.00 | (0.05) | 6.57 | (6.08) | 19.36 | |
| XCUR | Exicure | 0.24 | 6 per month | 8.61 | 0.03 | 21.22 | (11.88) | 63.80 | |
| KLTO | Klotho Neurosciences | 0.00 | 5 per month | 0.00 | (0.17) | 10.34 | (10.00) | 29.02 | |
| ANTX | AN2 Therapeutics | (0.17) | 9 per month | 0.00 | (0.02) | 4.55 | (4.39) | 32.31 | |
| CVKD | Cadrenal Therapeutics Common | (0.46) | 9 per month | 0.00 | (0.15) | 8.11 | (9.82) | 58.15 | |
| PSTV | Plus Therapeutics | (0.01) | 9 per month | 0.00 | (0.12) | 9.43 | (8.82) | 48.30 | |
| BOLD | Boundless Bio Common | (0.02) | 7 per month | 0.00 | (0.1) | 4.24 | (4.84) | 16.75 |
IBio Common Additional Predictive Modules
Most predictive techniques to examine IBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for IBio using various technical indicators. When you analyze IBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About IBio Common Predictive Indicators
The successful prediction of IBio Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as iBio Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of IBio Common based on analysis of IBio Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to IBio Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IBio Common's related companies. | 2020 | 2021 | 2025 | 2026 (projected) | Payables Turnover | 0.65 | 0.89 | 1.02 | 1.22 | Days Of Inventory On Hand | 6.74 | 375.49 | 431.82 | 422.46 |
Pair Trading with IBio Common
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IBio Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IBio Common will appreciate offsetting losses from the drop in the long position's value.Moving against IBio Stock
| 0.78 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.72 | ABP | Abpro Holdings | PairCorr |
| 0.71 | KURA | Kura Oncology | PairCorr |
| 0.7 | GNLX | Genelux Common | PairCorr |
| 0.69 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.53 | EDIT | Editas Medicine | PairCorr |
The ability to find closely correlated positions to IBio Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IBio Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IBio Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iBio Common Stock to buy it.
The correlation of IBio Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IBio Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iBio Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IBio Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out IBio Common Basic Forecasting Models to cross-verify your projections. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Will Biotechnology sector continue expanding? Could IBio diversify its offerings? Factors like these will boost the valuation of IBio Common. Market participants price IBio higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every IBio Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.40) | Revenue Per Share | Quarterly Revenue Growth 0.143 | Return On Assets | Return On Equity |
iBio Common Stock's market price often diverges from its book value, the accounting figure shown on IBio's balance sheet. Smart investors calculate IBio Common's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since IBio Common's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IBio Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if IBio Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IBio Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.